EUCTR2007-004165-17-IT进行中（未招募）不适用
Efficacy assessment of ceftriaxone therapy in patients with amyotrophic lateral sclerosis. - ND
AZIENDA OSPEDALIERA PISANA0 个研究点开始时间: 2007年10月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •a. definitive ALS, probable or probable with laboratory support; b. age > 18 years; c. disease duration < 36 months; d. patients in treatment with standard dose of riluzole, in association (or not) with E vitamin (400 mg/die for 30 days every 3 months) as antioxidant; e. negative pregnancy test.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •a. motoneuron disease except ALS; b. poor compliance with previous treatment; c. patients involved in other clinical trials; d. patients with history of sensitivity or intolerance to cephalosporins.
研究者
相似试验
已完成
不适用
The efficacy and safety evaluation of ceftriaxone and sulbactam combination (1.5 gram) in patients with skin and soft tissue infections: an open label, parallel, randomized, prospective comparative trialSkin and soft tissue infectionsInfections and InfestationsISRCTN76443564Ranbaxy Laboratories Ltd (India)400
尚未招募
不适用
Study comparing antibiotics versus placebo at time of catheter removal post robotic prostate removalurinary tract infectionprostate cancerACTRN12619000768190A/Prof John Yaxley800
已完成
2 期
The effect of cefotaxime on improvement of pediatric dysenteryDysentery.Gastroenteritis and colitis of unspecified originIRCT2016102211145N18Vice Chancellor of Research and Technology, Kashan University of Medical Sciences100
招募中
不适用
Susceptibility of Ceftriaxone on infectionsCTRI/2022/04/041997Alkem Laboratories
进行中（未招募）
1 期
CEFTRIAXONE NEONATAL THERAPY: A RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECT OF CEFTRIAXONE ON HYPERBILIRUBINEMIAHyperbilirubinemiaEUCTR2011-004417-16-NLSt. Elisabeth Hospital